Thomsen disease
| Thomsen disease | |
| ICD-10 | G71.1 |
|---|---|
| ICD-9 | 359.2 |
| OMIM | 160800 |
| DiseasesDB | 8736 |
| MeSH | D009224 |
|
WikiDoc Resources for Thomsen disease | |
|
Articles | |
|---|---|
|
Most recent articles on Thomsen disease Most cited articles on Thomsen disease | |
|
Media | |
|
Powerpoint slides on Thomsen disease | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Thomsen disease at Clinical Trials.gov Trial results on Thomsen disease Clinical Trials on Thomsen disease at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Thomsen disease NICE Guidance on Thomsen disease
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Thomsen disease Discussion groups on Thomsen disease Patient Handouts on Thomsen disease Directions to Hospitals Treating Thomsen disease Risk calculators and risk factors for Thomsen disease
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Thomsen disease | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Thomsen disease, a form of Myotonia congenita, is a muscular genetic disorder characterized by muscle stiffness (cramp) and an inability of the muscle to relax after a voluntary contraction. The affected muscle functions normally after a few repetitions.
Causes
It is associated with mutations in the chloride channel gene CLCN1.
Presentation
The disorder only affects voluntary muscles, so involuntary muscles such as the heart or muscles involved in the digestion process are not affected.
Treatment and prognosis
There is no known cure but some drugs may relieve symptoms. These include: Dilantin, Procainamide, Phenytoin and Mexiletine.
The disease is not fatal.
History
Julius Thomsen, a Danish physician, was the first to describe the disease, citing symptoms of his own family members.
External links
WikiDoc Research Resources for Thomsen disease | |
|---|---|
| Articles on Thomsen disease | Most recent articles on Thomsen disease • Most cited articles on Thomsen disease • Review articles on Thomsen disease • Articles on Thomsen disease in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Thomsen disease | Powerpoint slides on Thomsen disease • Images of Thomsen disease • Photos of Thomsen disease • Podcasts & MP3s on Thomsen disease • Videos on Thomsen disease |
| Evidence Based Medicine Regarding Thomsen disease | AND (Cochrane Database Syst Rev[http://worldselectshop.com/?id=9361 Cochrane Collaboration on Thomsen disease • Bandolier on Thomsen disease • TRIP on Thomsen disease |
| Cost Effectiveness of Thomsen disease | AND (Cost effectiveness) |
| group5 = Clinical Trials Involving Thomsen disease | list5 = Ongoing Trials on Thomsen disease at Clinical Trials.gov • Trial results on Thomsen disease • Clinical Trials on Thomsen disease at Google
| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Thomsen disease
| list6 = US National Guidelines Clearinghouse on Thomsen disease • NICE Guidance on Thomsen disease • NHS PRODIGY Guidance • FDA on Thomsen disease • CDC on Thomsen disease
| group7 = Textbook Information on Thomsen disease
| list7 = Books and Textbook Information on Thomsen disease
| group8 = Pharmacology Resources on Thomsen disease
| list8 =
AND (Dose)}} Dosing of Thomsen disease • AND (drug interactions)}} Drug interactions with Thomsen disease • AND (side effects)}} Side effects of Thomsen disease • AND (Allergy)}} Allergic reactions to Thomsen disease • AND (overdose)}} Overdose information on Thomsen disease • AND (carcinogenicity)}} Carcinogenicity information on Thomsen disease • AND (pregnancy)}} Thomsen disease in pregnancy • AND (pharmacokinetics)}} Pharmacokinetics of Thomsen disease •
| group9 = Genetics, Pharmacogenomics, and Proteinomics of Thomsen disease
| list9 =
AND (pharmacogenomics)}} Genetics of Thomsen disease • AND (pharmacogenomics)}} Pharmacogenomics of Thomsen disease • AND (proteomics)}} Proteomics of Thomsen disease
| group10 = Newstories on Thomsen disease
| list10 = Thomsen disease in the news • Be alerted to news on Thomsen disease • News trends on Thomsen disease</small>
| group11 = Commentary on Thomsen disease
| list11 =
Blogs on Thomsen disease
| group12 = Patient Resources on Thomsen disease | list12 = Patient resources on Thomsen disease • Discussion groups on Thomsen disease • Patient Handouts on Thomsen disease • Directions to Hospitals Treating Thomsen disease • Risk calculators and risk factors for Thomsen disease
| group13 = Healthcare Provider Resources on Thomsen disease
| list13 =
Symptoms of Thomsen disease • Causes & Risk Factors for Thomsen disease • Diagnostic studies for Thomsen disease • Treatment of Thomsen disease
| group14 = Continuing Medical Education (CME) Programs on Thomsen disease | list14 = CME Programs on Thomsen disease
| group15 = International Resources on Thomsen disease | list15 = Thomsen disease en Espanol • Thomsen disease en Francais
| group16 = Business Resources on Thomsen disease | list16 = Thomsen disease in the Marketplace • Patents on Thomsen disease
| group17 = Informatics Resources on Thomsen disease | list17 = List of terms related to Thomsen disease
}}
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies